226 related articles for article (PubMed ID: 36427396)
1. FBXW7 alleviates hyperglycemia-induced endothelial oxidative stress injury via ROS and PARP inhibition.
Li S; Deng J; Sun D; Chen S; Yao X; Wang N; Zhang J; Gu Q; Zhang S; Wang J; Zhu S; Zhu H; Li H; Xu X; Wei F
Redox Biol; 2022 Dec; 58():102530. PubMed ID: 36427396
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.
Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M
J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
Kiss L; Szabó C
Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
[TBL] [Abstract][Full Text] [Related]
5. Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha.
Zheng Z; Chen H; Wang H; Ke B; Zheng B; Li Q; Li P; Su L; Gu Q; Xu X
Diabetes; 2010 Sep; 59(9):2315-25. PubMed ID: 20566666
[TBL] [Abstract][Full Text] [Related]
6. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
Mabley JG; Soriano FG
Curr Vasc Pharmacol; 2005 Jul; 3(3):247-52. PubMed ID: 16026321
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
Guzyk MM; Tykhomyrov AA; Nedzvetsky VS; Prischepa IV; Grinenko TV; Yanitska LV; Kuchmerovska TM
Neurochem Res; 2016 Oct; 41(10):2526-2537. PubMed ID: 27255598
[TBL] [Abstract][Full Text] [Related]
8. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
[TBL] [Abstract][Full Text] [Related]
9. A novel transthyretin/STAT4/miR-223-3p/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy.
Shao J; Fan G; Yin X; Gu Y; Wang X; Xin Y; Yao Y
Mol Cell Endocrinol; 2019 Dec; 498():110541. PubMed ID: 31415795
[TBL] [Abstract][Full Text] [Related]
10. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.
Mathews MT; Berk BC
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):711-7. PubMed ID: 18239155
[TBL] [Abstract][Full Text] [Related]
11. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
Pacher P; Szabó C
Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
[TBL] [Abstract][Full Text] [Related]
12. PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.
Zakaria EM; El-Bassossy HM; El-Maraghy NN; Ahmed AF; Ali AA
Eur J Pharmacol; 2016 Nov; 791():444-454. PubMed ID: 27612628
[TBL] [Abstract][Full Text] [Related]
13. The Poly(ADP-Ribose)Polymerase-1 Inhibitor 1,5-Isoquinolinediol Attenuate Diabetes-Induced NADPH Oxidase-Derived Oxidative Stress in Retina.
Mohammad G; Alrashed SH; Almater AI; Siddiquei MM; Abu El-Asrar AM
J Ocul Pharmacol Ther; 2018 Sep; 34(7):512-520. PubMed ID: 29912609
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-Ribose) polymerase inhibition improves erectile function in diabetic rats.
Wan ZH; Li WZ; Li YZ; Chen L; Li GH; Hu WF; Peng S; Yu JJ; Guo F
J Sex Med; 2011 Apr; 8(4):1002-14. PubMed ID: 20807334
[TBL] [Abstract][Full Text] [Related]
15. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.
Soriano FG; Pacher P; Mabley J; Liaudet L; Szabó C
Circ Res; 2001 Oct; 89(8):684-91. PubMed ID: 11597991
[TBL] [Abstract][Full Text] [Related]
16. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
17. Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia.
Horváth EM; Benko R; Gero D; Kiss L; Szabó C
Life Sci; 2008 Jan; 82(3-4):205-9. PubMed ID: 18078960
[TBL] [Abstract][Full Text] [Related]
18. Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation.
Broniowska KA; Diers AR; Corbett JA; Hogg N
Biochemistry; 2013 Jun; 52(25):4364-72. PubMed ID: 23718265
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Szabó C; Biser A; Benko R; Böttinger E; Suszták K
Diabetes; 2006 Nov; 55(11):3004-12. PubMed ID: 17065336
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
